Clinical predictive model for brain metastasis at presentation in patients with non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Acevedo-Gadea, Carlos Rodrigo
Trinkaus, Kathryn
Govindan, Ramaswamy
Morgensztern, Daniel
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Washington Univ, St Louis, MO USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19158
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Surgical outcomes in elderly non-small-cell lung cancer (NSCLC) patients
    Skrzypski, M
    Dziadziuszko, R
    Kobierska-Gulida, G
    Rzyman, W
    Zurek, W
    Skokowski, J
    Jassem, E
    Jassem, J
    LUNG CANCER, 2004, 45 : S48 - S48
  • [22] Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy
    Zabel, A
    Debus, A
    LUNG CANCER, 2004, 45 : S247 - S252
  • [23] E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model
    Jin Young Yoo
    Seung-Ho Yang
    Jung Eun Lee
    Deog Gon Cho
    Hoon Kyo Kim
    Sung Hwan Kim
    Il Sup Kim
    Jae Taek Hong
    Jae Hoon Sung
    Byung Chul Son
    Sang Won Lee
    Journal of Neuro-Oncology, 2012, 109 : 219 - 227
  • [24] E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model
    Yoo, Jin Young
    Yang, Seung-Ho
    Lee, Jung Eun
    Cho, Deog Gon
    Kim, Hoon Kyo
    Kim, Sung Hwan
    Kim, Il Sup
    Hong, Jae Taek
    Sung, Jae Hoon
    Son, Byung Chul
    Lee, Sang Won
    JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 219 - 227
  • [25] Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
    Rogado, J.
    Fenor De La Maza, M. D.
    Pacheco-Barcia, V.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Ballesteros, A.
    Mondejar, R.
    Donnay, O.
    Obispo, B.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2107 - S2108
  • [26] Cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Pirker, Robert
    LUNG CANCER, 2012, 77 : S13 - S14
  • [27] Genomic analysis and clinical correlations of non-small cell lung cancer (NSCLC) brain metastasis (BM).
    Skakodub, Anna
    Tringale, Kathryn Ries
    Walch, Henry S.
    Vasudevan, Harish
    Eichholz, Jordan
    Kelly, Daniel W.
    Moss, Nelson S.
    Yu, Kenny Kwok Hei
    Li, Bob T.
    Mueller, Boris
    Yang, Jonathan T.
    Beal, Kathryn
    Imber, Brandon S.
    Gomez, Daniel Richard
    Schultz, Nikolaus
    Pike, Luke Roy George
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
    Passaro, A.
    Palazzo, A.
    Trenta, P.
    Mancini, M. L.
    Morano, F.
    Cortesi, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (22) : 3689 - 3700
  • [29] The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from non-small-cell lung cancer
    Deng, Yanming
    Feng, Weineng
    Wu, Jing
    Chen, Zecheng
    Tang, Yicong
    Zhang, Hua
    Liang, Jianmiao
    Xian, Haibing
    Zhang, Shunda
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 116 - 120
  • [30] Brain Metastasis in Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Bhatt, Vijaya R.
    Kedia, Shiksha
    Kessinger, Anne
    Ganti, Apar K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3162 - 3164
12345